Akershus University Hospital — Sponsor Intelligence | 9 EU Trials

Filter these 9 trials by condition, phase, country and more.

Open in Search →

9 Registered trials

4 Recruiting

3 Completed trials

1 Countries active

34 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 4 Phase IV: 3

100%

3 of 3 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Neck pain 1 Sepsis 1

Top IMPs

ATORVASTATIN 1 AZACITIDINE 1 CLOPIDOGREL 1 DABRAFENIB 1 DALTEPARIN SODIUM 1 DECITABINE 1 DEXAMETHASONE 1 DEXMEDETOMIDINE 1 EPINEPHRINE 1 ETOPOSIDE 1 FLUOROURACIL 1 FOLINIC ACID 1

All trials

9 total

Pharmacokinetic Profiles of Subcutaneous vs. Intravenous Midazolam in Terminally Ill Patients in Palliative Care (PK-MID-PAL-study) Pending

2025-521082-26-00 Phase II 1 country MIDAZOLAM HYDROCHLORIDE
Efficacy of Dexmedetomidine on Emergence Delirium in Children Undergoing Adenotonsillectomy: A Double-Blind Randomized Controlled Trial with… Pending

2025-524086-24-00 Phase III 1 country DEXMEDETOMIDINE; SODIUM CHLORIDE
Antiplatelet therapy added to standard thromboprophylaxis to prevent thrombosis in pancreatic cancer patients - a randomized clinical trial … Recruiting

2023-509022-22-00 Phase III 1 country CLOPIDOGREL; DALTEPARIN SODIUM
Aminoglycosides in early sepsis Recruiting

2024-519797-39-00 Phase IV 1 country
Antibiotic THErapy iN vIral Airway iNfections (ATHENIAN): An open labelled randomized controlled pragmatic trial to evaluate the efficacy an… Recruiting

2023-509286-20-00 Phase IV 1 country
Chiropractic spinal manipulative therapy for acute neck pain: a 4-armed clinical placebo randomized controlled trial Recruiting

2023-509624-17-00 Phase IV 1 country IBUPROFEN
Prevention of cardiac Dysfunction during Adjuvant breast cancer therapy: A Randomized, Placebo-controlled, Multicenter Trial (PRADA-II) Ended

2024-515323-11-00 Phase II 1 country VALSARTAN, SACUBITRIL
METIMMOX-2: Oxaliplatin Chemotherapy and Immunotherapy to Patients with the Common pMMR/MSS Type of Large Bowel Cancer Spread to Other Organ… Ended

2022-500027-76-00 Phase II 1 country DEXAMETHASONE; EPINEPHRINE; FLUOROURACIL; FOLINIC ACID; HYDROCORTISONE; METOCLOP…
Precision therapy versus standard therapy in Acute Myeloid Leukaemia and Myelodysplastic syndrome in elderly (PALM) – a phase II randomized … Ended

2023-509092-16-00 Phase II 1 country ATORVASTATIN; AZACITIDINE; DABRAFENIB; DECITABINE; ETOPOSIDE; HYDROXYCARBAMIDE; …

Showing 1–9 of 9 trials

← All sponsors A–Z